A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
Clinical trial NCT00858117 · COMPLETED
Trial details
- NCT number
- NCT00858117
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-26
- Primary completion
- 2010-03-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.